Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and over
Other
CO-ACT-001
NCT00094497
Last Modified:
1/7/2009
 
First Published:
3/13/2006
2.
Phase III Study of Neoadjuvant and Adjuvant Cisplatin-Based Chemotherapy and/or Surgical Resection in Young Patients With Stage I-IV Adrenocortical Tumor
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Under 22 at diagnosis
NCI
COG-ARAR0332
ARAR0332, NCT00304070
3.
Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
Over 18
Other
EudraCT 2007-007262-38
NCT00777244
First Published:
10/21/2008
4.
Phase II Randomized Study of Mitotane With Versus Without Anti-IGF-1R Recombinant Monoclonal Antibody IMC-A12 in Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Biomarker/Laboratory analysis, Treatment
Approved-not yet active
18 and over
NCI
UCCRC-16402A
16402A, 8199, NCT00778817
5.
Evaluation of Side Effects of Mitotane
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Approved-not yet active
Not specified
Other
Wue-ACC-Mitotane
NCT00568139
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute